Increasing impetus to research on gene therapy to treat sickle cell disease is a key factor contributing to the Global Sickle Cell Disease Treatment Market, says Fortune Business Insights in a report, titled “Sickle Cell Disease Treatment Market Size, Share and Global Trend by Treatment (Blood Transfusions, Medications, Bone Marrow Transplant, Others) and Geography Forecast till 2026.” The rising prevalence of sickle disease around the world is driving the global sickle cell disease treatment market.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/sickle-cell-disease-treatment-market-101009
Approval of Vexelotor by FDA Will Accelerate Growth
Global Blood Therapeutics (GBT), launched Voxelotor after receiving the Breakthrough Therapy Designation (BTD) from the FDA. Voxelotor, (previously called GBT440), will be used for the treatment of sickle cell disease (SCD). The launch of the new drug is predicted to boost the global sickle cell disease treatment revenue owing to the FDA’s decision to grant Voxelotor the first Breakthrough Therapy designation for the treatment of sickle. Furthermore, FDA approval for the treatment of severe complications associated with sickle cell disease is also expected to aid growth of the global sickle cell disease treatment market. For instance, Emmaus Medical, Inc., Endari received FDA approval for treatment of severe complications associated with sickle cell disease in adult and pediatric (above 5 years) patients. Endari is the second drug to be approved by the FDA.
Key players leading the global surgical robots market include
- Emmaus Medical Inc.,
- bluebird bio Inc.,
- Imara Inc.,
- Modus Therapeutics,
- Global Blood Therapeutics Inc.,
- Vertex Pharmaceuticals Incorporated
Request a Sample Copy of the Global Sickle Cell Disease Treatment Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/sickle-cell-disease-treatment-market-101009
KEY QUESTIONS ANSWERED:
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Fortune Business Insights?
- Blood Transfusions
- Bone Marrow Transplant
- North America (the USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
More Trending Topics From Fortune Business Insights: